ACCELERATION OF THE HEMOPOIETIC RECONSTITUTION IN MICE UNDERGOING BONE MARROW TRANSPLANTATION BY RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR

Authors:
  • TYTakeshi Yoshino
    Takeshi Yoshino
  • KHKunihiro Hattori
    Kunihiro Hattori
  • AKAkinori Kawamura
    Akinori Kawamura
  • HNHitoshi Nomura
    Hitoshi Nomura
  • NINobuo Imai
    Nobuo Imai
  • MOMasayoshi Ono
    Masayoshi Ono
Publisher website
Google Scholar
Abstract
We have investigated the effects of recombinant human granulocyte colony-stimulating factor (rG-CSF) on hemopoietic reconstitution after bone marrow transplantation (BMT) following lethal irradiation in mice. Mice received a daily administration of 10 micrograms/kg rG-CSF or control vehicle one through 21 days after BMT. Spleen colony-forming units (CFU-S), granulocyte-macrophage colony-forming units (CFU-GM), megakaryocyte colony-forming units (CFU-Meg), and erythroid burst-forming units (BFU-E) increased in both bone marrow and spleen of the rG-CSF-treated mice as compared with the control. This increase was evident during the administration period. In spite of the increase in the progenitor cells in bone marrow and spleen, only a recovery of neutrophils was accelerated in peripheral blood. Thus rG-CSF accelerated granulopoietic recovery in the BMT mice, with an enhanced recovery of the stem cells and the progenitors for erythrocytes and megakaryocytes. These results indicate the potential clinical usefulness of rG-CSF in the treatment of patients undergoing BMT.